- dTap is also recommended and reimbursed as a booster every 10 years from the previous dose in adults and to bone marrow transplant recipients and their family contacts who do not have specific detectable antibodies.
- Recommended and reimbursed for: children under 19 years old, born before 1 October 2017; people aged between 19 and 65 years, suffering of asplenia, chronic diseases or immunosuppressive diseases and specialized medical and healthcare personnel and auxiliary medical staff.
- For risk groups established by the World Health Organization. Also recommended and reimbursed for specialized medical and healthcare personnel and auxiliary medical staff. IIV is also recommended during pregnancy.
- Vaccination during pregnancy
- For adults aged 45–65 years without chronic medical conditions, the influenza vaccines are 50% reimbursed. For those aged 65 years and above the vaccine is fully reimbursed.
More information available at:
http://www.cnscbt.ro/index.php/calendarul-national-de-vaccinare
http://desprevaccin.ro/
https://www.colegfarm.ro/userfiles/file/Anexa%20la%20OMS%20964_2022%20_MO-Partea-I-nr.-320Bis.pdf
https://legislatie.just.ro/Public/DetaliiDocument/274488
MAJOR HISTORICAL CHANGES
Measles, mumps, rubella:
1979: Measles vaccine was introduced into national children vaccination schedule for children 9-11 months of age.
1994: Second measles vaccine dose was introduced into national children vaccination schedule for children 6-7 years of age (first school grade).
2002: 1st April first measles vaccine dose was moved from 9-11 month to 12-15 months to prepare for MMR introduction.
2003: Rubella vaccination was introduced into national children vaccination schedule for girls aged 14-15 years.
2004: MMR 1 was introduced into national children vaccination schedule for children at 12-15 month of age.
2005: October, MMR 2 was introduced into national children vaccination schedule for children at 6-7 years of age (first school grade).
2015: Change to the primary infant series. Moving to a 2, 4 and 11 months schedule for DTaP-IPV-Hib-HepB instead of a 2,4,6 and 12 month schedule. introduction of hexavalent vaccines.
Other vaccines:
2008: From October 2008, DTaP replaced DTwP and IPV replaced OPV. Both DTaP and IPV receommended as a combined quadrivalent vaccine at 2, 4 and 6 months. DTaP recommended at 4 years of age replaced DTwP given at 30-35 months of age.
2010: From January 2010, the quadrivalent vaccine DTPa-IPV was replaced by the pentavalent vaccine DTPa-IPV-HibV.
Date of last update: 16 Jan. 2024